Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including ...

South Korea’s ABL Bio Corp (KS: 298380) on Friday revealed that it has entered into a clinical trial collaboration and supply ...

AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...

AstraZeneca has entered into an exclusive license agreement with China’s CSPC Pharmaceutical to advance the development of an ...

BeiGene has launched Tevimbra (tislelizumab) in the USA for treating adults with esophageal squamous cell carcinoma (ESCC) ...

Kezar Life Sciences has paused its Phase IIb PALIZADE trial for zetomipzomib in lupus nephritis after four patient deaths, ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) revealed it is discontinuing the Phase II field study (NCT05201794) ...

The Irish Healthcare Association (IPHA), the representative body for the research-based biopharmaceutical industry in ...

ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of ...

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...

India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step ...

Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies ...